ENTYVIO

Takeda Pharmaceuticals Americas, Inc.

Formula & Concentration

ENTYVIO PEN – vedolizumab 108 mg/0.68 mL subcutaneous pen injector

Manufacturer

Takeda Pharmaceuticals Americas, Inc.

Indications

ENTYVIO PEN – vedolizumab 108 mg/0.68 mL subcutaneous pen injector

Product Options

Package Size

NDC #

Presentation

108 MG/0.68

64764-0108-21

PEN INJECTOR

300 MG/20 ML

64764-0300-20

VIAL

Shelf Life and Storage

Fridge (2-8°C)